Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
James Alpha Advisors was an asset management firm specializing in alternative investments and mutual funds with a focus on liquid alternatives such as global real estate portfolios. In August 2020, it entered into a strategic partnership with multi-affiliate manager Easterly Asset Management—which took a minority equity position—and subsequently rebranded to "Easterly Funds" effective August 23, 2021. The company is not involved in life sciences or healthcare sectors and does not have any drug development pipeline or therapeutic focus areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Easterly Funds.